| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2019 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31B+5.0% | $3.15B+7.7% | $2.93B+12.2% | $2.61B+12.8% | $2.31B+10.7% | $2.09B+4.1% | $2.01B+158.4% | $777.3M-1.5% | $789.4M+3.8% | $760.6M |
| Salaries, wages and benefits (including equity-based compensation expense of $31,708, $37,113, and $32,289, respectively) | $1.82B+7.7% | $1.69B+7.5% | $1.57B+12.8% | $1.39B+12.0% | $1.24B+7.7% | $1.15B+4.3% | $1.11B-33.3% | $1.66B+8.0% | $1.54B | — |
| Professional fees | $195.5M+3.0% | $189.7M+7.8% | $176.0M+11.4% | $158.0M+15.6% | $136.7M+13.5% | $120.5M+1.7% | $118.5M-47.9% | $227.4M+15.9% | $196.2M | — |
| Supplies | $118.0M+4.7% | $112.7M+6.3% | $106.0M+5.8% | $100.2M+10.5% | $90.7M+4.0% | $87.2M+2.0% | $85.5M-28.3% | $119.3M+4.3% | $114.4M | — |
| Rents and leases | $48.0M+0.3% | $47.9M+2.8% | $46.6M+2.4% | $45.5M+18.0% | $38.5M+3.1% | $37.4M+5.3% | $35.5M-55.8% | $80.3M+4.6% | $76.8M | — |
| Other operating expenses | $553.3M+25.5% | $440.8M+13.3% | $388.9M+11.3% | $349.3M+15.9% | $301.3M+14.9% | $262.3M+1.1% | $259.5M-26.8% | $354.5M+6.8% | $331.8M | — |
| Income from provider relief fund | -$6.4M | — | — | — | -$17.9M+45.5% | -$32.8M | — | — | — | — |
| Depreciation and amortization | $189.2M+26.5% | $149.6M+13.0% | $132.3M+12.4% | $117.8M+10.4% | $106.7M+12.0% | $95.3M+8.3% | $87.9M-44.6% | $158.8M+11.1% | $143.0M | — |
| Interest expense, net | $138.9M+19.3% | $116.4M+41.7% | $82.1M+17.7% | $69.8M-9.4% | $77.0M-51.3% | $158.1M-15.6% | $187.3M+1.0% | $185.4M+5.3% | $176.0M | — |
| Debt extinguishment costs | $1.3M | — | — | — | — | — | — | $810K | — | — |
| Legal settlements expense | $151.0M-61.7% | $394.2M | — | — | — | — | — | $22.1M | — | — |
| Loss on impairment | $1.01B+5734.1% | $17.3M+76.5% | $9.8M | — | — | — | $27.2M-91.9% | $337.9M+521.3% | $54.4M-83.9% | $337.9M |
| Gain on sale of property | -$8.7M+10.6% | -$9.7M | — | — | — | — | — | — | — | — |
| Transaction, legal and other costs | $163.6M+250.0% | $46.8M-24.6% | $62.0M+160.7% | $23.8M+86.2% | $12.8M+9.0% | $11.7M-44.6% | $21.2M-38.7% | $34.5M+42.2% | $24.3M | — |
| Total expenses | $4.38B+55.7% | $2.81B-4.8% | $2.95B+32.1% | $2.24B+9.7% | $2.04B+7.0% | $1.91B-1.2% | $1.93B-39.3% | $3.18B+22.4% | $2.60B | — |
| (Loss) income before income taxes | -$1.07B-411.8% | $341.9M+1448.1% | -$25.4M-106.8% | $374.1M+35.7% | $275.8M+50.0% | $183.8M+134.4% | $78.4M+58.2% | $49.6M-17.1% | $59.8M+62.2% | $36.9M |
| Provision for (benefit from) income taxes | $26.0M-66.4% | $77.4M+898.0% | -$9.7M-110.3% | $94.1M+39.3% | $67.6M+66.4% | $40.6M+61.9% | $25.1M+284.0% | $6.5M-82.4% | $37.2M | — |
| Net (loss) income | -$1.09B-512.9% | $264.5M+1788.8% | -$15.7M-105.6% | $280.0M+43.2% | $195.6M+129.2% | -$669.2M-707.7% | $110.1M+162.8% | -$175.5M-187.9% | $199.6M | — |
| Net income attributable to noncontrolling interests | -$10.8M-22.3% | -$8.9M-47.7% | -$6.0M+12.9% | -$6.9M-39.9% | -$4.9M-68.0% | -$2.9M-144.6% | -$1.2M-354.2% | -$264K-207.3% | $246K | — |
| Net (loss) income attributable to Acadia Healthcare Company, Inc. | -$1.10B-531.4% | $255.6M+106505100.0% | -$240-108.1% | $3K+41.9% | $2K+100.0% | -$672.1M-717.1% | $108.9M+155.9% | $42.6M-11.6% | $48.1M+63.3% | $29.5M |
| Basic | $90.7M-1.0% | $91.6M+0.7% | $90.9M+1.4% | $89.7M+1.0% | $88.8M+1.0% | $87.9M+0.3% | $87.6M+0.4% | $87.3M+0.4% | $86.9M+25572841.2% | $340 |
| Diluted | $90.7M-1.5% | $92.1M+1.2% | $90.9M-0.7% | $91.6M+0.8% | $90.8M+2.5% | $88.6M+0.9% | $87.8M+0.6% | $87.3M+0.3% | $87.1M+25605782.4% | $340 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.